In conclusion, the in vitro CRS models allowed us to examine the impact of genome editing-based mitigation strategies, indicating that disruption of both the CD40L and/or GM-CSF encoding loci in CAR T cells reduced IL-6 secretion from bystander monocytes. The gene discussed is IL6; the disease is congenital rubella syndrome.